Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced the Extraordinary General Meeting (EGM) for shareholders to be held on May 23, 2024, at the offices of Thomson Geer in Melbourne. Shareholders are urged to vote, preferably in advance, using the proxy forms available online or through their registry service, Automic. The company emphasizes the importance of shareholder votes and communication, offering electronic and hard copy options for receiving company information.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
